Staff Reporter
,
Australia
Photo from The Alfred Health website
Two groups are monitored for 12 months, with findings used to refine the AI model.
Australia’s Alfred Health is the lead site for PERSONAL, a clinical trial evaluating the use of artificial intelligence (AI) in prescribing epilepsy medication.
The trial will monitor two groups for 12 months, with findings used to refine the AI model and enhance its accuracy in epilepsy treatment.
One group’s doctor receives support from the model when prescribing medication, whilst the other prescribes without AI assistance. Participants are unaware of their group allocation.
Join
Healthcare Asia Magazine
community
Since you're here...
...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!